STAYCHA LEE: Open Payments
NPI 1346817061 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 35 payments from 7 companies in 2025. Trend: 2023 $466 · 2024 $393 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $416 |
| Organon LLC | 4 | $41 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Dexcom, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: UBRELVY, QULIPTA, VRAYLAR, NEXPLANON, SHINGRIX, Dexcom G6 Transmitter, ROTATEQ, TZIELD.
Industry payments across UT — which companies pay providers there.
